Loading company…
Numedii is a Menlo Park biotechnology company that uses AI and deep learning analytics to speed up drug discovery.
Founded in 2008 and headquartered in Menlo Park, US, Numedii develops a proprietary analytics platform that applies AI and deep learning to accelerate drug discovery and development. Its clients are pharmaceutical companies, research institutions and healthcare providers, mainly in North America and Europe. The company raised USD 2.00 mn in Series A funding on May 13, 2015, with participation from Claremont Creek Ventures and Lightspeed Venture Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in